Ototoxicity Completed Phase 1 Trials for Hyaluronic acid (DB08818)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04262336Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer TreatmentPrevention